Petrolatum Ointment
Generic Name: petrolatum ointment
Brand Names:
Hydrating Healing Skin Protectant
Purpose Skin protectant (ointment) Treatment or prevention of diaper rash
Overview
Purpose Skin protectant (ointment) Treatment or prevention of diaper rash
Uses
Directions apply as needed for diaper rash, change wet and soiled diapers promptly, cleanse the diaper area and allow to dry. Apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged.
Dosage
Do not use on deep or puncture wounds, animal bites, serious burns
Side Effects
Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days.
Warnings
Warnings For external use only When using this product do not get into eyes
Frequently Asked Questions
What is Petrolatum Ointment used for?▼
Directions apply as needed for diaper rash, change wet and soiled diapers promptly, cleanse the diaper area and allow to dry. Apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged.
What are the side effects of Petrolatum Ointment?▼
Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days.
What are the important warnings for Petrolatum Ointment?▼
Warnings For external use only When using this product do not get into eyes
Related Medications
Collagen Drops
collagen drops
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Eprosartan Mesylate
eprosartan mesylate
Dosage form: POWDER. Active ingredients: EPROSARTAN MESYLATE (1 kg/kg). Category: BULK INGREDIENT.
Emicizumab
emicizumab
11 DESCRIPTION Emicizumab-kxwh is a humanized monoclonal modified immunoglobulin G4 (IgG4) bispecific antibody binding factor IXa and factor X. Emicizumab-kxwh has an approximate molecular weight of 145.6 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells. Emicizumab-kxwh has no structural relationship or sequence homology to FVIII and, as such, does not induce or enhance the development of direct inhibitors to FVIII.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.